Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 8/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.54 |
| ▸ | CTSK | P43235 | 7/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1904291 | 1.00 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL8823986 | 1.00 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL28012371 | 0.98 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL18982338 | 0.98 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL3056203 | 0.98 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Hydrochloric Acid SCHEMBL27573111 | 0.98 | ITGB3 (0.53) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| Acetic Acid SCHEMBL6813701 | 0.96 | ITGB3 (0.54) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL14366085 | 0.95 | ITGB3 (0.50) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL6646260 | 0.95 | ITGB3 (0.50) | ITGB3ITGA2BCTSKCTSSHDAC4 | |
| SCHEMBL17445159 | 0.94 | ITGB3 (0.51) | ITGB3ITGA2BCTSKCTSSHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10292940-B2 | Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) | 2019-05-21 | — | — | US | claimed |
| EP-3241852-B1 | HYALURONIC ACID-BASED AMPHIPHILIC POLYMER, PREPARATION METHOD AND APPLICATION THEREOF | BRIGHTGENE BIO MEDICAL TECH CO LTD (CN) | 2018-10-17 | — | — | EP | claimed |
| US-20180092858-A1 | Hyaluronic Acid-Based Amphiphilic Polymer, Preparation Method and Application Thereof | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) | 2018-04-05 | — | — | US | claimed |
| CN-104497171-A | Hyaluronic-acid-based amphiphilic polymer as well as preparation method and application thereof | UNIV SOOCHOW | 2015-04-08 | — | — | CN | claimed |
| US-20250388615-A9 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | ARDELYX, INC. (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250066410-A1 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | ARDELYX, INC. (US) | 2025-02-27 | — | — | US | disclosed |
| CN-117838875-B | Drug delivery system for local delivery of therapeutic agents and uses thereof | 上海椿安生物医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-12084472-B2 | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists | ARDELYX, INC. (US) | 2024-09-10 | — | — | US | disclosed |
| CN-117838875-A | Drug delivery system for local delivery of therapeutic agents and uses thereof | 上海椿安生物医药科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-115867319-B | Drug delivery system for local delivery of therapeutic agents and uses thereof | 上海椿安生物医药科技有限公司 | 2024-01-02 | — | — | CN | disclosed |
| US-20230256106-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | COVAL BIOPHARMA (SHANGHAI) CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20230256106-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | COVAL BIOPHARMA (SHANGHAI) CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-20090081803-A1 | POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | GLUMETRICS INC. (US) | 2009-03-26 | — | — | US | disclosed |
| US-20090081803-A1 | POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | GLUMETRICS INC. (US) | 2009-03-26 | — | — | US | disclosed |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | SAXENA RESEARCH, LLC | 2008-11-20 | — | — | US | disclosed |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | SAXENA RESEARCH, LLC | 2008-11-20 | — | — | US | disclosed |
| EP-0184550-B1 | 5-AMINO-4-HYDROXY VALERYL AMIDE DERIVATIVES | CIBA-GEIGY AG (CH) | 1992-03-18 | — | — | EP | disclosed |
| EP-0236734-A2 | 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups | CIBA-GEIGY AG (CH) | 1987-09-16 | — | — | EP | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |
| EP-0010405-B1 | STABLE IMMUNOCHEMICAL ASSAY REAGENT FOR THE DETERMINATION OF HAPTENS, AND ASSAY METHOD USING SAID REAGENT | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1983-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10292940-B2 | Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof | CD44, HCAR1, ASGR1 | ITGB3 905/4885ITGA2B 546/4885CTSK 2825/4885 |
| US-20180092858-A1 | Hyaluronic Acid-Based Amphiphilic Polymer, Preparation Method and Application Thereof | CD44, HCAR1, ASGR1 | ITGB3 905/4885ITGA2B 546/4885CTSK 2825/4885 |
| US-20230256106-A1 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | TIE1, TEK, KDR | ITGB3 538/4885ITGA2B 374/4885CTSK 1600/4885 |
| US-20250066410-A1 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | GPR119, GIPR, GLP1R | ITGB3 3266/4885ITGA2B 4241/4885CTSK 4778/4885 |
| US-20090081803-A1 | POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | SLC2A4, SLC2A2, SLC2A1 | ITGB3 4632/4885ITGA2B 4350/4885CTSK 4503/4885 |
| US-20250388615-A9 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | GPR119, GIPR, FFAR3 | ITGB3 3570/4885ITGA2B 4631/4885CTSK 4767/4885 |
| US-12084472-B2 | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists | GPR119, GIPR, GLP1R | ITGB3 3266/4885ITGA2B 4241/4885CTSK 4778/4885 |
| US-20080286291-A1 | Betulinol Derivatives as Anti-Hiv Agents | BET1, NFATC1, CD4 | ITGB3 1678/4885ITGA2B 3345/4885CTSK 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.